Overview
To Evaluate if the Medication Gabapentin Lessens Vulvar Pain
Status:
Terminated
Terminated
Trial end date:
2008-03-01
2008-03-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Colleen Stockdale
University of IowaTreatments:
Gabapentin
gamma-Aminobutyric Acid
Criteria
Inclusion Criteria:- All women, ages 18 years and older with the diagnosis of vulvodynia or VVS (by
Friedrich's criteria), who present to the University of Iowa Vulvar Vaginal Disease
Clinic.
Exclusion Criteria:
- Vulvar Vaginal Disease clinic patients who are pregnant, less than 3 months
postpartum, breast-feeding, non-English speaking, or have contraindication to use of
gabapentin due to allergy or renal disease (serum creatinine level greater than 1.4).